| Financial Year |
March 31 2022 |
| Monetary Funds |
548,085.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
151.00 |
| Advances to Suppliers |
-- |
| Other Receivables |
110,905.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
82.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,989,292.67 |
| Total Current Assets |
15,648,516.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
282,994.75 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
105,428,565.72 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
105,711,560.47 |
| Total Assets |
121,360,076.95 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
34,449,904.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,041,937.54 |
| Taxes Payable |
29,762,314.24 |
| Interest Payable |
30,717,525.81 |
| Dividend Payable |
-- |
| Other payables |
459,838,360.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
658,722,477.77 |
| Other Current Liabilities |
180,464.44 |
| Sub-Total of Current Liabilities |
1,187,367,109.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,666,666.64 |
| Total Liabilities |
1,193,033,775.65 |
| Paid-In Capital(Or Share Stock) |
326,760,374.00 |
| Capital Surplus |
92,139,624.14 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,489,824,624.58 |
| Minority Stockholder's Interest |
-749,072.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-1,070,924,626.44 |
| Owner's Equity（Stockholder's Equity） |
-1,071,673,698.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
121,360,076.95 |
